Cancer remains the second leading cause of death in the United States. Advances in our understanding of neoplastic progression have provided new targets for intervention which can be utilized as smart assays for drug discovery. Natural products or compounds modeled on them have found significant utility in the treatment of cancer. In this proposal we seek to substantiate our hypothesis that actinomycetes which live in association with deep-sea invertebrates have undergone a unique evolution which in turn provided them with unique biosynthetic capabilities. This genetic information can be extracted and recombinant clones which express both the native genome and novel pathways derived from combinatorial biology can be produced. These clones will produce a diverse library of compounds for cancer drug discovery using target based assays. The project will be carried out in collaboration with the Sherman group from the University of Minnesota (Project 2) who will conduct combinatorial biology studies using DNA from HBOI originated isolates and Novartis Pharmaceutical Corporation (Project 3) who will carry out assays on extracts from clones which incorporate actinomycete biosynthetic gene sequences. Active actinomycete derived clones generated by Minnesota will be chemically deconvoluted at HBOI. The specific goals of the HBOI research project will be to: 1. Provide a diverse set of actinomycetes to Project 2 (U. of Minnesota) for cosmid preparation of native genome sequences and combinatorial biology studies. [Years 1-5 respectively: 60, 80, 60, 40, 40 isolates/year] 2. Using selective media/conditions, isolate additional actinomycete strains from deep water marine invertebrates for use in years 2-5 of the project. 3. Ferment active Streptomyces venezuelae clones derived from actinomycete DNA and carry out bioassay guided purification and structure elucidation of the active components.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
United States
Zip Code
Ramaswamy, Aishwarya V; Sorrels, Carla M; Gerwick, William H (2007) Cloning and biochemical characterization of the hectochlorin biosynthetic gene cluster from the marine cyanobacterium Lyngbya majuscula. J Nat Prod 70:1977-86
Beck, Zachary Q; Sherman, David H (2006) Development of an internally quenched fluorogenic substrate for kinetic analysis of thioesterases. Anal Biochem 349:309-11
Magarvey, Nathan A; Beck, Zachary Q; Golakoti, Trimurtulu et al. (2006) Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts. ACS Chem Biol 1:766-79
Beck, Zachary Q; Aldrich, Courtney C; Magarvey, Nathan A et al. (2005) Chemoenzymatic synthesis of cryptophycin/arenastatin natural products. Biochemistry 44:13457-66
Fortman, J L; Sherman, David H (2005) Utilizing the power of microbial genetics to bridge the gap between the promise and the application of marine natural products. Chembiochem 6:960-78
Chang, Zunxue; Sitachitta, Namthip; Rossi, James V et al. (2004) Biosynthetic pathway and gene cluster analysis of curacin A, an antitubulin natural product from the tropical marine cyanobacterium Lyngbya majuscula. J Nat Prod 67:1356-67
Wright, Amy E; Chen, Ying; Winder, Priscilla L et al. (2004) Lasonolides C-g, five new lasonolide compounds from the sponge Forcepia sp. J Nat Prod 67:1351-5
Edwards, Daniel J; Marquez, Brian L; Nogle, Lisa M et al. (2004) Structure and biosynthesis of the jamaicamides, new mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya majuscula. Chem Biol 11:817-33
Salomon, Christine E; Magarvey, Nathan A; Sherman, David H (2004) Merging the potential of microbial genetics with biological and chemical diversity: an even brighter future for marine natural product drug discovery. Nat Prod Rep 21:105-21
Magarvey, Nathan A; Keller, Jessica M; Bernan, Valerie et al. (2004) Isolation and characterization of novel marine-derived actinomycete taxa rich in bioactive metabolites. Appl Environ Microbiol 70:7520-9

Showing the most recent 10 out of 12 publications